3 August 2023 Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors read more
11 July 2023 IconOVir Bio Announces First Patient Dosed in Phase 1 Clinical Trial of its Lead Product Candidate, ICVB-1042 read more
10 July 2023 Centessa Pharmaceuticals Announces Dosing of First Subject in Registrational PRESent-2 Study Evaluating SerpinPC for the Treatment of Hemophilia B without Inhibitors read more
29 June 2023 Kyverna Therapeutics Announces First Patient Enrolled in Phase 1 Clinical Trial of CD19 CAR T-cell Therapy for Lupus Nephritis in the U.S. read more
5 January 2023 Affini-T Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference read more
